Back | Next |
home / stock / ctmx / ctmx message board
Subject | By | Source | When |
---|---|---|---|
Wait for $1.90s to reload for next run | tw0122 | investorshub | 01/09/2023 3:09:58 AM |
$CTMX, is one of the best stock right | dinogreeves | investorshub | 01/07/2023 2:01:51 AM |
znewcar1: $CTMX 40% v51,2M c2.52 f66,084M H2.98 ML1.33 YL1.67 gapNcrap | znewcar1 | investorshangout | 01/06/2023 9:37:32 PM |
$CTMX 2.60 BREAK | TheFinalCD | investorshub | 01/06/2023 8:13:23 PM |
Uh oh see ya at 2.20 | Triple nickle | investorshub | 01/06/2023 4:41:16 PM |
Yall beat the horses Ill make bank | Triple nickle | investorshub | 01/06/2023 4:28:58 PM |
Added again | Triple nickle | investorshub | 01/06/2023 4:28:22 PM |
$CTMX like most small cap biotech/pharma stocks the | surf1944 | investorshub | 01/06/2023 4:26:35 PM |
Again, to beat a dead horse let me | alstocks | investorshub | 01/06/2023 4:25:13 PM |
One day rsi gunna start curlin upward baby | Triple nickle | investorshub | 01/06/2023 4:24:15 PM |
Added | Triple nickle | investorshub | 01/06/2023 4:22:57 PM |
Respectfully disagree. | alstocks | investorshub | 01/06/2023 4:10:27 PM |
It is a simple big open gap in | surf1944 | investorshub | 01/06/2023 3:46:21 PM |
looks like an easy to borrow stock. i | HNDRXX | investorshub | 01/06/2023 3:41:33 PM |
aGREED | TheFinalCD | investorshub | 01/06/2023 3:40:39 PM |
Here we go slap the ask | Triple nickle | investorshub | 01/06/2023 3:39:40 PM |
I went through the same thing after | alstocks | investorshub | 01/06/2023 3:26:05 PM |
Itll move just be patient 2.45 and boom | Triple nickle | investorshub | 01/06/2023 3:22:21 PM |
had one of the best news any SC | HNDRXX | investorshub | 01/06/2023 3:20:33 PM |
2.45 ? And up | Triple nickle | investorshub | 01/06/2023 3:05:19 PM |
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
CytomX Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a firesid...
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024. “Chris has mad...